Diabetes Increases the Mortality of Patients with COVID-19: a Meta-analysis

Overview

Journal Acta Diabetol

Specialty Endocrinology

Date 2020 Jun 26

PMID 32583078

Citations 79

Authors

Zeng-Hong Wu

Yun Tang

Qing Cheng

Affiliations

Soon will be listed here.

Abstract

Aims: Nowadays, the ongoing pandemic of COVID-19 caused by the novel coronavirus Syndrome-Coronavirus-2 (SARS-CoV-2) is an emerging, rapidly evolving situation. Complications such as hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19.

Methods: No meta-analysis has explored if or not diabetes related to mortality of patients with COVID-19. Therefore, this meta-analysis first aims to explore the possible clinical mortality between diabetes and COVID-19, analyze if diabetes patients infected with SARS-CoV-2 are exposed to the worst clinical prognostic risk, and to evaluate the reliability of the evidence.

Results: Our results showed a close relationship between diabetes and mortality of COVID-19, with a pooled OR of 1.75 (95% CI 1.31-2.36; P = 0.0002). The pooled data were calculated with the fixed effects model (FEM) as no heterogeneity appeared in the studies. Sensitivity analysis showed that after omitting any single study or converting a random effect model to FEM, the main results still held.

Conclusions: Our meta-analysis showed that diabetes increases the mortality of patients with COVID-19. These results indicated the disturbance of blood glucose in the COVID-19 patients. More importantly, this meta-analysis grades the reliability of evidence for further basic and clinical research into the diabetes dysfunction in COVID-19 patients.

Citing Articles

Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD Registry.

Gujral U, Vanasse L, Goyal A, Quyyumi A, Ayers C, Das S BMJ Open. 2024; 14(12):e084087.

PMID: 39632106 PMC: 11624769. DOI: 10.1136/bmjopen-2024-084087.

Impact of COVID-19 on Psychiatric Patients: The Role of Vaccination, Comorbidities, and Biomarkers in Clinical Outcomes.

Argyropoulos K, Argyropoulou-Grizanou A, Jelastopulu E J Clin Med. 2024; 13(19).

PMID: 39408010 PMC: 11477535. DOI: 10.3390/jcm13195950.

The Impact of COVID-19 on Children and Adolescents with Chronic Illness.

Nearchou F, Flinn C Adv Exp Med Biol. 2024; 1457:385-399.

PMID: 39283439 DOI: 10.1007/978-3-031-61939-7_22.

Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China.

Xu Y, Sang L, Wang Y, Li Z, Wu H, Deng X BMC Infect Dis. 2024; 24(1):706.

PMID: 39026159 PMC: 11256567. DOI: 10.1186/s12879-024-09287-z.

Clinical characteristics and outcomes of COVID-19 in children and adolescents with diabetes in Daegu, South Korea.

Lee N, Kim Y, Kim Y, Kang S, Jang K, Kim H Ann Pediatr Endocrinol Metab. 2024; 29(3):167-173.

PMID: 38956753 PMC: 11220390. DOI: 10.6065/apem.2346124.062.

References

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Knapp S . Diabetes and infection: is there a link?--A mini-review. Gerontology. 2012; 59(2):99-104. DOI: 10.1159/000345107. View

Yang J, Lin S, Ji X, Guo L . Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2009; 47(3):193-9. PMC: 7088164. DOI: 10.1007/s00592-009-0109-4. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J . COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020; 201(11):1380-1388. PMC: 7258639. DOI: 10.1164/rccm.202002-0445OC. View

Yuan M, Yin W, Tao Z, Tan W, Hu Y . Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020; 15(3):e0230548. PMC: 7082074. DOI: 10.1371/journal.pone.0230548. View

Luzi L, Radaelli M . Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. 2020; 57(6):759-764. PMC: 7130453. DOI: 10.1007/s00592-020-01522-8. View

Nikolich-Zugich J, Knox K, Rios C, Natt B, Bhattacharya D, Fain M . SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020; 42(2):505-514. PMC: 7145538. DOI: 10.1007/s11357-020-00186-0. View

10.

Du R, Liang L, Yang C, Wang W, Cao T, Li M . Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020; 55(5). PMC: 7144257. DOI: 10.1183/13993003.00524-2020. View

11.

Fadini G, Morieri M, Longato E, Avogaro A . Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020; 43(6):867-869. PMC: 7103097. DOI: 10.1007/s40618-020-01236-2. View

12.

Ghosh A, Gupta R, Misra A . Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr. 2020; 14(4):273-276. PMC: 7129346. DOI: 10.1016/j.dsx.2020.04.001. View

13.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

14.

Bindom S, Lazartigues E . The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2008; 302(2):193-202. PMC: 2676688. DOI: 10.1016/j.mce.2008.09.020. View

15.

Banik G, Alqahtani A, Booy R, Rashid H . Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia. Virol Sin. 2016; 31(1):81-4. PMC: 7090713. DOI: 10.1007/s12250-015-3679-z. View

16.

Onodera T, Jenson A, Yoon J, Notkins A . Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science. 1978; 201(4355):529-31. DOI: 10.1126/science.208156. View

17.

Yang J, Feng Y, Yuan M, Yuan S, Fu H, Wu B . Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006; 23(6):623-8. DOI: 10.1111/j.1464-5491.2006.01861.x. View

18.

Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

19.

Wang B, Li R, Lu Z, Huang Y . Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020; 12(7):6049-6057. PMC: 7185114. DOI: 10.18632/aging.103000. View

20.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368:m1091. PMC: 7190011. DOI: 10.1136/bmj.m1091. View